37777-75-6 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
(2-iodo-6-nitro-phenyl)-acetic acid is used as a reagent for the synthesis of various organic molecules, contributing to the development of new drugs and pharmaceutical compounds.
Used in Production of Fine Chemicals and Agrochemicals:
(2-iodo-6-nitro-phenyl)-acetic acid is used as a reagent in the production of fine chemicals and agrochemicals, aiding in the creation of specialized chemical products for various applications.
Used in Materials Science:
(2-iodo-6-nitro-phenyl)-acetic acid is used as a precursor for the preparation of advanced materials, playing a role in the development of new materials with specific properties for various industries.
It is important to handle (2-iodo-6-nitro-phenyl)-acetic acid with caution, as it may have harmful effects on human health and the environment if not used properly.
Check Digit Verification of cas no
The CAS Registry Mumber 37777-75-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,7,7 and 7 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 37777-75:
(7*3)+(6*7)+(5*7)+(4*7)+(3*7)+(2*7)+(1*5)=166
166 % 10 = 6
So 37777-75-6 is a valid CAS Registry Number.
37777-75-6Relevant articles and documents
PYRROLO-NITROGENOUS HETEROCYCLIC DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF
-
Page/Page column 99, (2010/04/23)
The invention provides new pyrrolo-nitrogenous heterocyclic derivatives represented by formula (I) or their salts, the preparation thereof, pharmaceutical compositions containing such derivatives and the use of such derivatives as therapeutic agents, espe
PYRROLO-NITROGENOUS HETEROCYCLIC DERIVATIES,THE PREPARATION AND THE PHARMCETICAL USE THEEOF
-
Page/Page column 90, (2010/04/23)
The invention provides new pyrrolo-nitrogenous heterocyclic derivatives represented by formula (I) or their salts, the preparation thereof, pharmaceutical compositions containing such derivatives and the use of such derivatives as therapeutic agents, especially as protein kinase inhibitors, wherein each substituent in formula (I) is same as defined in the description.
